An investor in NASDAQ:NH shares filed a lawsuit against NantHealth Inc over alleged Securities Laws violations.
Investors who purchased shares of NantHealth Inc (NASDAQ:NH) have certain options and for certain investors are short and strict deadlines running. Deadline: May 8, 2017. NASDAQ:NH investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
Theplaintiff alleges on behalf of purchasers of NantHealth Inc (NASDAQ:NH) common shares in connection with the Company’s initial public offering (“IPO”) which occurred on or about June 1, 2016 and/or between June 1, 2016, and March 6, 2017, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Defendants made false and/or misleading statements, and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose that Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth, that, as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability, that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders, that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016, and that, as a result of the foregoing, the Company’s financial statements and Defendants’ statements about NantHealth’s business, operations, and prospects, were materially false and misleading.
NantHealth Inc reported that its annual Total Revenue rose from $33.92 million in 2014 to $58.30 million in 2015 and that its Net Loss declined from $84.42 milion in 2014 to $72.01 million in 2015.
On March 6, 2017, a news organization focused on medical industry reporting published an article alleging that NantHealth Inc founder, Patrick Soon-Shiong, had donated $12 million to the University of Utah from three different tax-exempt entities controlled by him under a contract that required the University to funnel most of that money into NantHealth Inc. The report alleged that the scheme allowed NantHealth Inc to inflate the number of test orders it reported to investors.
Those who purchased NASDAQ:NH shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego